“G-Protein-coupled estrogen receptor (GPER)-specific agonist G-1 reduces cell proliferation in gastrointestinal cancer cells independently of GPER1 receptor presence” (2026) Prospects in Pharmaceutical Sciences, 24(2), pp. 79–89. doi:10.56782/pps.743.